Health Care Originals Announces Strategic Alliance With Healthport For Australia And New Zealand

ROCHESTER, N.Y., Nov. 28, 2018 /PRNewswire/ -- Health Care Originals (HCO) announces its strategic alliance with Healthport. HCO is a leading manufacturer of medical wearables that complement digital heath technology. This alliance equips Healthport to support the rapidly growing digital health landscape of Australia and New Zealand.

Healthport scours the world to identify pioneering wearable products and proudly works alongside startups or established innovative technology companies.  Healthport's partners are responsible for moulding some of the most cutting-edge technological advancements to develop life changing, wearable medical devices that enable greater control and independence for those faced with chronic health conditions. Healthport's Management team have a long history working within the field of chronic health and are passionate about achieving positive outcomes for patients.

"The team at HCO were impressed by Healthport and their alignment not only around improved patient outcomes, but also the progression of healthcare monitoring from an office setting to the home. This transition to consumer-focused healthcare, wherein we provide consumers with the right information at the right time to positively impact and control their healthcare outcomes, is central to our view of the future of healthcare. The Healthport team had previous experience and a history of excellent execution in the delivery of technology and services that successfully bridged that gap and this made us very comfortable that they are the right partner for us," said Jared Dwarika, Co-Founder of HCO.

"Health Care Originals (HCO) has the leading wearable for collecting and processing physiological data of the respiratory system.  At Healthport we recognised early on that HCO's ADAMM™ and ADAMM-RSM™- Real time Respiratory monitoring systems, are products with unparalleled ability to empower patients to independently monitor and respond to the needs of respiratory disease. Asthma is an example of one chronic respiratory disease where HCO's technology can help. In Australia, we have the dubious honour of having one of the highest levels of Asthma in the world, with many patients requiring close supervision.   Given the levels of respiratory disease in Australia, HCO's ADAMM™ has the ability to dramatically reduce emergencies and increase independence for many thousands of patients.  In achieving these aims, ADAMM™ also has the capacity to have a positive impact on the growing burden to the public health purse. We are looking forward to making that a reality for Australia and New Zealand," said Brett Doyle, CEO of Healthport.

ABOUT HEALTH CARE ORIGINALS:

Health Care Originals (HCO), (www.healthcareoriginals.com), a WT Innovation World Cup winner, is recognized for its Breakthrough Innovation that integrates IoT technologies to empower everyone through improved understanding and management of their health and medical conditions. HCO's current wearable solutions are optimized for respiratory system applications, providing revolutionary, actionable insight into illnesses like asthma and COPD, respiratory syndromes, research, health & safety and competitive sports. HCO is a resident company of the Johnson & Johnson Innovation JLABS @ NYC.

SOURCE Health Care Originals

Related Links

http://www.healthcareoriginals.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED